- Snyder H.M.
- Corriveau R.A.
- Craft S.
- Faber J.E.
- Greenberg S.
- Knopman D.
- Lamb B.T.
- Montine T.
- Nedergaard M.
- Schaffer C.B.
- Schneider J.A.
- Wellington C.
- Wilcock D.M.
- Zipfel G.J.
- Zlokovic B.
- Bain L.J.
- Bosetti F.
- Galis Z.S.
- Koroshetz W.
- Carrillo M.C.
- Wardlaw J.M.
- Markin S.J.
- Valdes Hernandez M.C.
- Armitage P.A.
- Heye A.K.
- Chappell F.M.
- Munoz-Maniega S.
- Sakka E.
- Shuler K.
- Dennis M.S.
- Thrippleton M.J.
- Poggesi A.
- Pantoni L.
- Inzitari D.
- Fazekas F.
- Ferro J.
- O'Brien J.
- Hennerici M.
- Scheltens P.
- Erkinjuntti T.
- Visser M.
- Langhorne P.
- Chabriat H.
- Waldemar G.
- Wallin A.
- Wahlund A.
2001-2011: A decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease?.
- Fernando M.S.
- Simpson J.E.
- Matthews F.
- Brayne C.
- Lewis C.E.
- Barber R.
- Kalaria R.N.
- Forster G.
- Esteves F.
- Wharton S.B.
- Shaw P.J.
- O'Brien J.T.
- Ince P.G.
- Nation D.A.
- Sweeney M.D.
- Montagne A.
- Sagare A.P.
- D'Orazio L.M.
- Pachicano M.
- Sepehrband F.
- Nelson A.R.
- Buennagel D.P.
- Harrington M.G.
- Benzinger T.L.S.
- Fagan A.M.
- Ringman J.M.
- Schneider L.S.
- Morris J.C.
- Chui H.C.
- Law M.
- Toga A.W.
- Zlokovic B.V.
- Montagne A.
- Nation D.A.
- Sagare A.P.
- Barisano G.
- Sweeney M.D.
- Chakhoyan A.
- Pachicano M.
- Joe E.
- Nelson A.R.
- D'Orazio L.M.
- Buennagel D.P.
- Harrington M.G.
- Benzinger T.L.S.
- Fagan A.M.
- Ringman J.M.
- Schneider L.S.
- Morris J.C.
- Reiman E.M.
- Caselli R.J.
- Chui H.C.
- Tcw J.
- Chen Y.
- Pa J.
- Conti P.S.
- Law M.
- Toga A.W.
- Zlokovic B.V.
- Montagne A.
- Nikolakopoulou A.M.
- Zhao Z.
- Sagare A.P.
- Si G.
- Lazic D.
- Barnes S.R.
- Daianu M.
- Ramanathan A.
- Go A.
- Lawson E.J.
- Wang Y.
- Mack W.J.
- Thompson P.M.
- Schneider J.A.
- Varkey J.
- Langen R.
- Mullins E.
- Jacobs R.E.
- Zlokovic B.V.
NO Is a Key Regulator of Cardiovascular and Cerebrovascular Functions
- Imamura A.
- Takahashi R.
- Murakami R.
- Kataoka H.
- Cheng X.W.
- Numaguchi Y.
- Murohara T.
- Okumura K.
Brains of Partial eNOS-Deficient Mice Display AD-Like Pathology

Partial eNOS-Deficient Mice Display Key Features of CSVD

BBB Leakage Is One of the Earliest Pathologies Detected in Partial eNOS-Deficient Mice
Middle-Aged eNOS-Deficient Mice Elicit Severe White Matter Pathology, Neurodegeneration in Cortical Layers II/III and V, and Gait Disturbances
- Poggesi A.
- Pantoni L.
- Inzitari D.
- Fazekas F.
- Ferro J.
- O'Brien J.
- Hennerici M.
- Scheltens P.
- Erkinjuntti T.
- Visser M.
- Langhorne P.
- Chabriat H.
- Waldemar G.
- Wallin A.
- Wahlund A.
2001-2011: A decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease?.
- Fernando M.S.
- Simpson J.E.
- Matthews F.
- Brayne C.
- Lewis C.E.
- Barber R.
- Kalaria R.N.
- Forster G.
- Esteves F.
- Wharton S.B.
- Shaw P.J.
- O'Brien J.T.
- Ince P.G.

- Montagne A.
- Nikolakopoulou A.M.
- Zhao Z.
- Sagare A.P.
- Si G.
- Lazic D.
- Barnes S.R.
- Daianu M.
- Ramanathan A.
- Go A.
- Lawson E.J.
- Wang Y.
- Mack W.J.
- Thompson P.M.
- Schneider J.A.
- Varkey J.
- Langen R.
- Mullins E.
- Jacobs R.E.
- Zlokovic B.V.
Potential Molecular Mechanisms Linking Hypoperfusion and BBB Leakage with White Matter Pathology
- Verdura E.
- Herve D.
- Scharrer E.
- Del Mar Amador M.
- Guyant-Marechal L.
- Philippi A.
- Corlobe A.
- Bergametti F.
- Gazal S.
- Prieto-Morin C.
- Beaufort N.
- Bail B.
- Viakhireva I.
- Dichgans M.
- Chabriat H.
- Haffner C.
- Tournier-Lasserve E.

- Verdura E.
- Herve D.
- Scharrer E.
- Del Mar Amador M.
- Guyant-Marechal L.
- Philippi A.
- Corlobe A.
- Bergametti F.
- Gazal S.
- Prieto-Morin C.
- Beaufort N.
- Bail B.
- Viakhireva I.
- Dichgans M.
- Chabriat H.
- Haffner C.
- Tournier-Lasserve E.
Comparison with Other Models of Chronic Hypoperfusion
- Duncombe J.
- Kitamura A.
- Hase Y.
- Ihara M.
- Kalaria R.N.
- Horsburgh K.
- Hainsworth A.
- Allan S.M.
- Boltze J.
- Cunningham C.
- Farris C.
- Head E.
- Ihara M.
- Issacs J.D.
- Kalaria R.N.
- Lesnik Oberstein S.A.M.J.
- Moss M.B.
- Nitzsche B.
- Rosenberg G.A.
- Rutten J.W.
- Salkovic-Petrisic M.
- Troen A.M.
Concluding Remarks and Perspective
Acknowledgments
Author Contributions
References
- Vascular contributions to cognitive impairment and dementia including Alzheimer's disease.Alzheimers Dement. 2015; 11: 710-717
- Mixed brain pathologies account for most dementia cases in community-dwelling older persons.Neurology. 2007; 69: 2197-2204
- The pathobiology of vascular dementia.Neuron. 2013; 80: 10
- The overlap between vascular disease and Alzheimer's disease - lessons from pathology.BMC Med. 2014; 12: 206
- Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges.Lancet Neurol. 2010; 9: 689-701
- Silent MRI infarcts and the risk of future stroke: the cardiovascular health study.Neurology. 2001; 57: 1222-1229
- Silent brain infarcts: a systematic review.Lancet Neurol. 2007; 6: 611-619
- Microinfarct pathology, dementia, and cognitive systems.Stroke. 2011; 42: 722-727
- Cerebral microinfarcts: the invisible lesions.Lancet Neurol. 2012; 11: 272-282
- Cardiovascular risk factors and small vessel disease of the brain: blood pressure, white matter lesions, and functional decline in older persons.J Cereb Blood Flow Metab. 2016; 36: 132-142
- Lacunar infarcts: a review.Cerebrovasc Dis. 1991; 1: 311-320
- Risk factor profile of cerebral small vessel disease and its subtypes.J Neurol Neurosurg Psychiatry. 2007; 78: 702-706
- Reduced white matter CBF in ischaemic leukoaraiosis demonstrated using quantitative exogenous contrast based perfusion MRI.J Neurol Psychiat Neurosurg. 2000; 69: 48-53
- Understanding the role of the perivascular space in cerebral small vessel disease.Cardiovasc Res. 2018; 114: 1462-1473
- Mechanisms underlying sporadic cerebral small vessel disease: insights from neuroimaging.Lancet Neurol. 2013; 12: 483-497
- Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?.Stroke. 2003; 34: 806-812
- Lacunar stroke is associated with diffuse blood-brain barrier dysfunction.Ann Neurol. 2009; 65: 194-202
- Blood-brain barrier: ageing and microvascular disease: systematic review and meta-analysis.Neurobiol Aging. 2009; 30: 337-352
- Blood–brain barrier breakdown in acute and chronic cerebrovascular disease.Stroke. 2011; 42: 3323-3328
- Blood-brain-barrier permeability and long-term clinical and imaging outcomes in cerebral small vessel disease.Stroke. 2013; 44: 525-527
- Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study.Alzheimers Dement. 2017; 13: 634-643
- Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain.Neurosci Lett. 2010; 486: 246-521
- Blood-brain barrier leakage in relation to white matter hyperintensity volume and cognition in small vessel disease and normal aging.Brain Imaging Behav. 2019; 13: 389-395
- Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the cardiovascular health study.Stroke. 1996; 27: 1274-1282
- 2001-2011: A decade of the LADIS (Leukoaraiosis And DISability) study: what have we learned about white matter changes and small-vessel disease?.Cerebrovasc Dis. 2011; 32: 577-588
- White matter lesions in an unselected cohort of the elderly: molecular pathology suggests origin from chronic hypoperfusion injury.Stroke. 2006; 37: 1391-1398
- White matter degeneration in vascular and other ageing-related dementias.J Neurochem. 2018; 144: 617-633
- Blood-brain barrier leakage in patients with early Alzheimer disease.Radiology. 2016; 281: 527-535
- Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction.Nat Med. 2019; 25: 270-276
- APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.Nature. 2020; 581: 71-76
- Pericytes regulate the blood-brain barrier.Nature. 2010; 468: 557-561
- Blood-brain barrier: from physiology to disease and back.Physiol Rev. 2019; 99: 21-78
- Pericyte degeneration causes white matter dysfunction in the mouse central nervous system.Nat Med. 2018; 24: 326-337
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine.Nature. 1980; 288: 373-376
- Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.Proc Natl Acad Sci U S A. 1987; 84: 9265-9269
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.Nature. 1987; 327: 524-526
- Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.Nature. 1988; 336: 385-388
- Nitric oxide and the cerebral circulation.Am J Pathol. 1994; 25: 703
- The role of nitric oxide in pre-synaptic plasticity and homeostasis.Front Cell Neurosci. 2013; 7: 190
- Endothelial NOS: perspective and recent developments.Br J Pharmacol. 2019; 176: 189-196
- Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice.Cardiovasc Res. 2008; 77: 19-29
- Elevated blood pressures in mice lacking endothelial nitric oxide synthase.Proc Natl Acad Sci U S A. 1996; 93: 13176-13181
- Hypertension in mice lacking the gene for endothelial nitric oxide synthase.Nature. 1995; 377: 239-242
- Coronary hemodynamics in endothelial NO synthase knockout mice.Circ Res. 1998; 82: 186-194
- Premature death and age-related cardiac dysfunction in male eNOS-knockout mice.J Mol Cell Cardiol. 2004; 37: 671-680
- Structure of cerebral arterioles in mice deficient in expression of the gene for endothelial nitric oxide synthase.Circ Res. 2004; 95: 822-829
- Endothelial nitric oxide synthase deficiency causes collateral vessel rarefaction and impairs activation of a cell cycle gene network during arteriogenesis.Circ Res. 2010; 106: 1870-1881
- Role of endothelial nitric oxide synthase in arteriogenesis after stroke in mice.Neuroscience. 2009; 159: 744-750
- Endothelial nitric oxide gene haplotypes and risk of cerebral small-vessel disease.Stroke. 2004; 35: 654-659
- Endothelial nitric oxide synthase gene polymorphisms and the risk of silent brain infarction.Int J Mol Med. 2010; 25: 819-823
- eNOS, metabolic syndrome and cardiovascular disease.Trends Endocrinol Metab. 2009; 20: 295-302
- Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase.Circulation. 2001; 104: 342-345
- Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice.Swiss Med Wkly. 2003; 133: 360-363
- Endothelial nitric oxide synthase (eNOS) knockout mice have defective mitochondrial beta-oxidation.Diabetes. 2007; 56: 2690-2696
- The effects of endothelial nitric oxide synthase gene polymorphisms on endothelial function and metabolic risk factors in healthy subjects: the significance of plasma adiponectin levels.Eur J Endocrinol. 2000; 58: 189-195
- Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis.Hypertension. 2006; 48: 700-710.i
- The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged.Arch Neurol. 2009; 66: 300-305
- The 894G > T (Glu298Asp) variant in the endothelial NOS gene and MTHFR polymorphisms influence homocysteine levels in patients with cognitive decline.Neuromol Med. 2011; 13: 167-174
- Significant negative correlations between capillary expressed eNOS and Alzheimer lesion burden.Neurosci Lett. 2009; 463: 244-248
- Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration.Neurobiol Aging. 2000; 21: 309-319
- Cerebral amyloid angiopathy in the elderly.Ann Neurol. 2011; 70: 871-880
- Differential regulation of BACE1 expression by oxidative and nitrosative signals.Mol Neurodegener. 2011; 6: 17
- Endothelial nitric oxide deficiency promotes Alzheimer's disease pathology.J Neurochem. 2013; 127: 691-700
- Metabolic stress modulates Alzheimer's β-secretase gene transcription via SIRT1-PPARγ-PGC-1 in neurons.Cell Metab. 2013; 17: 685-694
- Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment.Mol Neurodegener. 2015; 10: 24
- Distinct cerebral perfusion patterns in FTLD and AD.Neurology. 2010; 75: 881
- Effects of hypoperfusion in Alzheimer's disease.J Alzheimers Dis. 2011; 26: 123-133
- Cerebral perfusion insufficiency and relationships with cognitive deficits in Alzheimer's disease: a multiparametric neuroimaging study.Sci Rep. 2018; 8: 1541
- Superior water maze learning and increase in fear related behavior in the eNOS3/3 mouse together with monoamine changes in cerebellum and ventral striatum.J Neurosci. 2000; 20: 6684-6700
- Unaltered radial maze performance and brain acetylcholine of the endothelial nitric oxide synthase knockout mouse.Neuroscience. 2001; 107: 561-570
- Imaging of cerebrovascular pathology in animal models of Alzheimer's disease.Front Aging Neurosci. 2014; 6: 32
- Rodent models of cerebral microinfarct and microhemorrhage.Stroke. 2018; 49: 803-810
- On myelinated axon plasticity and neuronal circuit formation and function.J Neurosci. 2017; 37: 10023-10034
- How do cells of the oligodendrocyte lineage affect neuronal circuits to influence motor function, memory and mood?.Front Cell Neurosci. 2018; 12: 399
- Cells of the oligodendroglial lineage, myelination, and remyelination.Biochim Biophys Acta. 2011; 1812: 184-193
- Quantitative analysis of a vulnerable subset of pyramidal neurons in Alzheimer's disease, II: primary and secondary visual cortex.J Comp Neurol. 1990; 301: 55-64
- Pyramidal neurons of the prefrontal cortex in post-stroke, vascular and other ageing-related dementias.Brain. 2014; 137: 2509-2521
- The corticohippocampal circuit, synaptic plasticity, and memory.Cold Spring Harb Perspect Biol. 2015; 7: a021733
- Rapid disruption of axon–glial integrity in response to cerebral hypoperfusion.J Neurosci. 2011; 31: 18185-18194
- Pericyte loss leads to circulatory failure and pleiotrophin depletion causing neuron loss.Nat Neurosci. 2019; 22: 1089-1098
- Role of transforming growth factor-β superfamily signaling pathways in human disease.Biochim Biophys Acta. 2008; 1782: 197-228
- Chronic overproduction of transforming growth factor-β1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice.Am J Pathol. 2000; 156: 139-150
- Elevation of transforming growth factor-beta 1 level in cerebrospinal fluid of patients with communicating hydrocephalus after subarachnoid hemorrhage.Stroke. 1994; 25: 1400-1404
- Heterozygous HTRA1 mutations are associated with autosomal dominant cerebral small vessel disease.Brain. 2015; 138: 2347-2358
- Pericyte-derived bone morphogenetic protein 4 underlies white matter damage after chronic hypoperfusion.Brain Pathol. 2018; 28: 521-535
- Transgenic overexpression of BMP4 increases astroglial and decreases oligodendroglial lineage commitment.Dev Biol. 2003; 255: 164-177
- Bone morphogenetic proteins: inhibitors of myelination in development and disease.Vitam Horm. 2015; 99: 195-222
- Bone morphogenetic proteins 4, 6, and 7 are up-regulated in mouse spinal cord during experimental autoimmune encephalomyelitis.J Neurosci Res. 2008; 6: 125-135
- Myelination in multiple sclerosis lesions is associated with regulation of bone morphogenetic protein 4 and its antagonist Noggin.Int J Mol Sci. 2019; 20: 154
- Bmp4-directed nuclear cyan fluorescent protein provides a tool for live imaging and reveals cellular resolution of Bmp4 expression patterns during embryogenesis.Int J Dev Biol. 2010; 54: 931-938
- A versatile murine model of subcortical white matter stroke for the study of axonal degeneration and white matter neurobiology.J Vis Exp. 2016; 109: 53404
- Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice.Proc Natl Acad Sci U S A. 2010; 107: 17716-17720
- Oral nitrite restores age-dependent phenotypes in eNOS-null mice.JCI Insight. 2018; 3: e122156
- Targeting pericytes for therapeutic approaches to neurological disorders.Acta Neuropathol. 2018; 136: 507-523
- Cerebral small vessel disease (CSVD) - lessons from the animal models.Front Physiol. 2019; 10: 1317
- Chronic cerebral hypoperfusion: a key mechanism leading to vascular cognitive impairment and dementia: closing the translational gap between rodent models and human vascular cognitive impairment and dementia.Clin Sci (Lond). 2017; 131: 2451-2468
- Translational models for vascular cognitive impairment: a review including larger species.BMC Med. 2017; 15: 16
- The stroke-prone spontaneously hypertensive rat: how good is it as a model for cerebrovascular diseases?.Cell Mol Neurobiol. 2004; 24: 639-646
- Functional deficits induced by cortical microinfarct.J Cereb Blood Flow Metab. 2017; 37: 3599-3614
- Does pathology of small venules contribute to cerebral microinfarcts and dementia?.J Neurochem. 2018; 144: 517-526
Article Info
Publication History
Footnotes
Small Blood Vessel Disease in the Brain Theme Issue
Supported in part by NIH grants R21 AG041934 , NS091593 , and R01 AG058467 (F.-L.L.) and Alzheimer Foundation ZEN-16-362441 (F.-L.L.), NIH grant R01 NS120327 (F.-L.L. and F.-M.Z.), NIH grant R01NS097671 (F.-M.Z.), NIH grants NS106138 , AG063031 , and NS097775 (A.Y.S.), and NIH grant AR73024378 (R.R.).
G.L., X.C., and L.C. contributed equally to this work.
Disclosures: None declared.
This article is part of a review series on small blood vessel disease in the brain, addressing current knowledge, new mechanisms, biomarkers, and therapeutic approaches.